background image

Triple Negative Breast Cancer Clinical Trials

Find clinical trials for triple negative breast cancer. Search for triple negative breast cancer clinical trials in different cities and states across the United States.

Filter
1
Active & Responsive

Study of XB010 in Subjects With Solid Tumors

for
Locally Advanced or Metastatic Solid Tumors,
Location: Duarte CA, St Louis MO, Huntersville NC,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT06545331

Phase1, Recruiting

ZAP-IT: ZN-c3 + Carboplatin + Pembrolizumab in MTNBC

for
Breast Cancer, Breast Cancer Female,
Location: Boston MA
Sponsor: Filipa Lynce, MD

Sex: All

Age: 18+

Code: NCT06351332

Phase1, Phase2, Recruiting

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

for
Advanced Solid Tumor, TNBC - Triple-Negative Breast Cancer,
Location: Coral Gables FL, Bronx NY, Portland OR
Sponsor: SillaJen, Inc.

Sex: All

Age: 18+

Code: NCT05768932

Phase1, Recruiting

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

for
Triple Negative Breast Cancer, Non Small Cell Lung Cancer,
Location: Hartford CT, Norwalk CT, Miami FL, Basking Ridge NJ,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT03808337

Phase2, Recruiting

A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)

for
Leptomeningeal Disease, Triple Negative Breast Cancer,
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT05809752

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Tetrathiomolybdate (TM) Plus Capecitabine

for
Triple Negative Breast Cancer, Residual Disease
Location: Lebanon NH
Sponsor: Dartmouth-Hitchcock Medical Center

Sex: All

Age: 18 - 70

Code: NCT06134375

Phase1, Phase2, Recruiting

A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors

for
Metastatic Solid Tumor, Recurrent Solid Tumor,
Location: Orlando FL, Atlanta GA, Boston MA, St Louis MO,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06238479

Phase1, Recruiting

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab

for
Non-Small Cell Lung Cancer,
Location: Duarte CA, Chicago IL, Fort Wayne IN, Indianapolis IN,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT05005403

Phase1, Recruiting

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

for
Non Small Cell Lung Cancer, Triple Negative Breast Cancer,
Location: Margate FL, Orlando FL, Sarasota FL, Boston MA,
Sponsor: Compass Therapeutics

Sex: All

Age: 18+

Code: NCT06150664

Phase1, Recruiting

A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers

for
Cancer, Neoplasms, Metastatic Cancer,
Location: Edmonton, Ottawa, Toronto, Montreal
Sponsor: Ocellaris Pharma, Inc.

Sex: All

Age: 18+

Code: NCT04260802

Phase1, Phase2, Recruiting